INTRODUCTION
Genomic DNA is constantly exposed to various genotoxic agents, such as UV light, DNA-damaging chemicals, and endogenous oxidative stress. When DNA lesions escape repair, they usually block the progress of replication forks catalyzed by high-fidelity DNA polymerases (Pols). Translesion synthesis (TLS), an essential mechanism for bypassing such blocks, is catalyzed by specialized Pols, including Y family Pols (Y-Pols). Y-Pols display low stringency of the active site and a lack of proofreading, thus contributing to mutagenesis (Friedberg et al., 2005; Lehmann et al., 2007; Yang and Woodgate, 2007) . On the other hand, each Y-Pol has distinct specificity for different DNA lesions, and some can be error free on a specific lesion. Y-Pols are evolutionarily conserved from bacteria to humans, and mammals have four members: Pol h, Pol k, Pol i, and REV1 (Friedberg et al., 2005; Lehmann et al., 2007; Yang and Woodgate, 2007) .
UV irradiation causes several types of DNA lesions, including cyclobutane pyrimidine dimers (CPDs) and (6-4) photoproducts ((6-4)PPs). Whereas (6-4)PPs are efficiently removed by nucleotide excision repair, CPDs frequently escape this mechanism. Pol h, a prototypic member of the Y-Pols, can perform errorfree TLS across CPDs by incorporating correct bases on the opposite strand McCulloch et al., 2004) . Indeed, its deficiency is responsible for the variant form of Xeroderma pigmentosum (XP-V), an inherited human disorder characterized by UV hypersensitivity and increased susceptibility to skin cancers (Johnson et al., 1999; Masutani et al., 1999) . Where replication has stalled at UV-damaged sites, Pol h is recruited to the chromatin, which can be microscopically observed as nuclear foci (Kannouche et al., 2001) . For this relocalization of Pol h, Rad6/Rad18-mediated monoubiquitination of PCNA, a replication accessory protein, has a critical role Watanabe et al., 2004) . Pol h binds unmodified PCNA via two PCNA-interacting peptide (PIP) domains (PIP-1 and PIP-2) (Acharya et al., 2008; Haracska et al., 2001 ), but it binds monoubiquitinated PCNA (Ub-PCNA) with much higher affinity through the interaction between the ubiquitin (Ub) moiety of Ub-PCNA and the Ub-binding zinc-finger (UBZ) domain of Pol h (Bienko et al., 2005; Plosky et al., 2006) . In addition, increasing attention has centered on the posttranslational regulation of Pol h in higher eukaryotes (Chen et al., 2008; Kim and Michael, 2008) . Of note, previous studies have documented that the chaperone/proteasome system has an important role in the regulation of bacterial and yeast Y-Pols. In E. coli, the GroE chaperone helps Y-Pols fold correctly (Donnelly and Walker, 1989; Layton and Foster, 2005) , and in Saccharomyces cerevisiae, the proteasome controls Pol h stability and modulates mutagenesis (McIntyre et al., 2006 Podlaska et al., 2003; Skoneczna et al., 2007) . These findings raised the possibility that similar mechanisms are involved in the posttranslational regulation of Y-Pols in human cells.
Hsp90 is an abundant, evolutionarily conserved molecular chaperone that has a vital role in conformational regulation of a relatively selective group of ''client'' proteins (Pearl et al., 2008) . This function of Hsp90 depends on its ability to bind and hydrolyze ATP. Natural compounds such as geldanamycin bind to the ATP-binding pocket of Hsp90 and inhibit its function. Hsp90 not only promotes proper folding of newly synthesized proteins into mature forms, but also regulates stability, trafficking, and protein interactions of mature clients. To fulfill these functions, Hsp90 usually cooperates with Hsp70 and cochaperones, such as p23 and CDC37. Many Hsp90 clients play key roles in cell survival/growth; representative clients include receptor and nonreceptor protein kinases (e.g., ErbB2 and Akt), steroid receptors, transcriptional factors (e.g., p53), and telomerase. In addition, Hsp90 promotes stability and activity of mutant or overexpressed oncoproteins (Whitesell and Lindquist, 2005) . Thus, Hsp90 is an attractive target for cancer therapeutics. Indeed, specific inhibitors of Hsp90 are under development as promising antitumor agents, and geldanamycin analogs, such as 17-allylamino-17-demethoxygeldanamycin (17-AAG), are currently in clinical trials (Neckers, 2006; Pearl et al., 2008) .
Some evidence, mainly from synergistic antitumor effects of Hsp90 inhibitors and DNA-damaging agents, suggests that (E) FLAG-Pol h was synthesized in RRL with or without 10 mM 17-AAG. Reaction mixtures were immunoprecipitated and immunoblotted as indicated. As a negative control, reaction mixture without FLAG-Pol h template was similarly analyzed (Mock).
Hsp90 regulates cellular genotoxic responses (Bagatell et al., 2005; Camphausen and Tofilon, 2007) . Several studies have revealed molecular mechanisms for these observations. For instance, Hsp90 regulates the Chk1-mediated cell-cycle checkpoint (Arlander et al., 2003) and the Fanconi anemia pathway (Oda et al., 2007) . However, roles of Hsp90 in DNA damage responses have just begun to be explored. We previously isolated Pol h complex (Yuasa et al., 2006) and detected Hsp90 in the complex (unpublished data). These findings prompted us to test the hypothesis that Hsp90 regulates Pol h-mediated TLS. In the present work, we found that Hsp90 specifically associates with Pol h and regulates its levels and localization. We provide evidence that Hsp90 promotes the stability and efficient binding of Pol h with Ub-PCNA. Furthermore, we show that Hsp90 regulates UV-induced cytotoxicity and mutagenesis in a Pol h-dependent manner. The present work establishes a molecular link between Hsp90 and TLS, which may have important implications for understanding aberrant genotoxic responses of tumor cells.
RESULTS

Physical Interaction between Hsp90 and Pol h
To address the hypothesis that Hsp90 regulates Pol h, we first studied their physical association. When Pol h was transiently expressed in HEK293 T cells, Hsp90 coimmunoprecipitated with Pol h in a 17-AAG-sensitive manner ( Figure 1A) . For further studies, we generated two stable clones expressing GFP-Pol h in HeLa and HEK293 T cells (HeLa/GFP-Pol h and 293 T/GFPPol h cells, respectively). GFP-Pol h was expressed in these cell lines at levels 15-to 20-fold greater than that of endogenous Pol h (data not shown). In HeLa/GFP-Pol h cells, Hsp90 and its cochaperone p23 coimmunoprecipitated with GFP-Pol h in a 17-AAG-sensitive manner ( Figure 1B ). Hsp90a and Hsp90b, two major Hsp90 isoforms, specifically associated with Pol h. The interaction between Hsp90 and GFP-Pol h was confirmed in reciprocal immunoprecipitation using an anti-Hsp90 antibody ( Figure 1C) . Similar results were obtained in 293 T/GFP-Pol h cells (data not shown). Furthermore, endogenous Pol h specifically associated with Hsp90, and this association was inhibited in the presence of 17-AAG ( Figure 1D ). To test their interaction in vitro, we synthesized Pol h in rabbit reticulocyte lysates (RRL), which are a rich source of Hsp90. In this mixture, Pol h associated with Hsp90 in a 17-AAG-sensitive manner ( Figure 1E ).
Collectively, these data demonstrate the specific interaction between Pol h and Hsp90.
Effects of Hsp90 Inhibition on UV-Induced Nuclear Focus Formation of Pol h To examine a role of Hsp90 in the regulation of Pol h, we next studied the effects of 17-AAG on its subcellular localization. GFP-Pol h, transiently expressed in Pol h-deficient human fibroblasts XP2SASV3, localized in the nucleoplasm in most cells at basal states and accumulated into nuclear foci after UV irradiation ( Figure S1 available online), consistent with previous data (Kannouche et al., 2001 ). This focus formation was markedly suppressed in the presence of 17-AAG ( Figure S1 ). Similarly, in HeLa/GFP-Pol h and 293 T/GFP-Pol h cells, UV irradiation dramatically increased Pol h foci-positive cells, in which GFPPol h colocalized with PCNA (Figures 2A and 2B) . Significantly, 17-AAG suppressed the GFP-Pol h focus formation but had little effect on PCNA focus formation (Figures 2A and 2B ). These data suggest that 17-AAG suppresses GFP-Pol h accumulation at replication stalling sites. In addition, nuclear fluorescence signals of GFP-Pol h were significantly attenuated in 17-AAG-treated HeLa/GFP-Pol h cells, suggesting reduced expression of GFPPol h (Figure 2A ). Moreover, cytoplasmic fluorescent aggregates appeared after 17-AAG treatment in a significant proportion ($15%) of HeLa/GFP-Pol h cells, but not in HeLa/GFP cells ( Figure S2 ). This probably means that GFP-Pol h newly synthesized in the cytoplasm is misfolded into insoluble aggregates. Such attenuation of nuclear fluorescence signals or appearance of protein aggregates was not observed in 293 T/GFP-Pol h cells ( Figure 2B and data not shown). These differences probably reflect a slow turnover rate of Pol h in these cells (data not shown).
17-AAG Induces Proteasomal Degradation of Pol h
We next studied the biochemical basis of the 17-AAG-induced suppression of Pol h nuclear focus formation in HeLa/GFP-Pol h cells. 17-AAG reduced GFP-Pol h protein levels in whole-cell lysates (WCL) and in the soluble fraction in a dose-dependent manner within the range of 10-500 nM, which was consistent with known effective doses of the drug (data not shown). The reduction of GFP-Pol h levels in the soluble and chromatin fractions was greater compared with that in the WCL (Figure S3A ). Conversely, GFP-Pol h levels increased in the insoluble fraction ( Figure S3A ), consistent with the appearance of cytoplasmic aggregates. Because 17-AAG had little effect on UV-induced monoubiquitination of PCNA in HeLa/GFP-Pol h cells (data not shown), the 17-AAG-induced reduction of Pol h in the soluble fraction is presumably the main reason for its reduced localization in nuclear foci. This notion is supported by the high mobility of Pol h between nucleoplasm and replication foci (Sabbioneda et al., 2008; Solovjeva et al., 2005) . The 17-AAG-induced reduction of GFP-Pol h was almost completely blocked in the presence of proteasome inhibitors MG132 and ALLN ( Figure S3B ). In addition, 17-AAG enhanced polyubiquitination of GFP-Pol h in the absence or presence of MG132 ( Figure S3C ). Together, these results suggest that Hsp90 protects GFP-Pol h from protein degradation via the ubiquitinproteasome pathway. In further support for the role of Hsp90 in the regulation of Pol h, RNAi-mediated depletion of Hsp90a and/or Hsp90b reduced GFP-Pol h protein levels ( Figure S3D ) and markedly suppressed UV-induced formation of GFP-Pol h foci in HeLa/GFP-Pol h cells (data not shown).
We next studied the effects of Hsp90 inhibition on endogenous Pol h protein levels. 17-AAG induced a rapid, $80% reduction in the total amount of endogenous Pol h in HeLa cells and in other cell lines (Figures 3A and 3B) . These effects were blocked by MG-132 ( Figure 3B ). Cycloheximide chase analysis revealed that the half-life of Pol h was significantly reduced in the presence of 17-AAG ( Figure 3C ). Moreover, 17-AAG had little effect on mRNA levels of Pol h ( Figure 3D ). These results indicate that Hsp90 is a physiological regulator of Pol h stability in some cell types.
Hsp90
Regulates the Interaction between Pol h and Ub-PCNA In 293 T/GFP-Pol h cells, 17-AAG had mild effects on GFP-Pol h protein levels in WCL and in the soluble fractions and more greatly suppressed chromatin-bound GFP-Pol h ( Figure S3A ). Thus, it seems that Hsp90 inhibition impairs Pol h accumulation in replication foci through different mechanisms in a cell type-dependent manner: 17-AAGinduced reduction of protein levels plays a predominant role in some cell types, whereas distinct mechanisms predominate in other cell types. This notion was supported from differential effects of 17-AAG on UV-induced nuclear focus formation and protein levels of GFP-Pol h in XP2SASV3, MCF7, and COS7 cells (Table S1 ). The exact reason for these cell typedependent differences is unknown at present but may be related to their distinct tissue/organ origins.
17-AAG reduced chromatin-bound GFP-Pol h amounts in UV-irradiated 293 T/GFP-Pol h cells, whereas it had little effect on PCNA monoubiquitination ( Figure 4A, bottom) . Therefore, we reasoned that Hsp90 may affect the interaction between GFP-Pol h and Ub-PCNA. To support this notion, 17-AAG significantly inhibited the UV-induced interaction between GFPPol h and Ub-PCNA in these cells ( Figure 4A, top) . To examine the effect of 17-AAG on the interaction between endogenous Pol h and Ub-PCNA, we transiently expressed Myc-Rad18 in HEK293 T cells. In these cells, 17-AAG inhibited the UV-induced interaction between Pol h and Ub-PCNA ( Figure 4B ), confirming the physiological role of Hsp90-mediated regulation of Pol h.
To further analyze the molecular mechanisms by which Hsp90 regulates the interaction between Pol h and Ub-PCNA, we carried out GST pull-down experiments. Consistent with previous results (Bienko et al., 2005; Haracska et al., 2001; Kannouche et al., 2004; Plosky et al., 2006) , GST-PCNA and GST-Ub bound to GFP-Pol h wild-type protein, but not to GFP-Pol h proteins with a PIP-2 mutation (FF707, 708AA) and a UBZ mutation (D652A), respectively (data not shown). For quantitative analyses of protein interactions, various doses of cell extracts from vehicle-or 17-AAG-treated 293 T/GFP-Pol h cells were incubated with GST-proteins, and amounts of Pol h in the input and the pull-down fraction were determined by immunoblotting. Remarkably, Pol h extracted from 17-AAG-treated cells exhibited much lower binding to GST-PCNA and GST-Ub than did Pol h from vehicle-treated cells ( Figure 5A ).
As internal controls for GST-PCNA and GST-Ub pull-downs, we analyzed PARP-1 and HDAC6 levels, respectively, in the same samples. PARP-1 directly binds to PCNA, and HDAC6 directly binds to Ub (Boyault et al., 2007; Frouin et al., 2003) . The results show that 17-AAG had little effect on PARP-1 binding to GST-PCNA and on HDAC6 binding to GST-Ub ( Figure S4 ). Furthermore, 17-AAG had little effect on Pol h binding to GST-REV1 (826-1251) ( Figure S5 ). Pol h directly binds to the C-terminal region of REV1 (Ohashi et al., 2004; Tissier et al., 2004) . To ensure that the effects of 17-AAG depend on Hsp90, GFP-Pol h (594-713), which contains UBZ and PIP-2 domains but fails to bind Hsp90 (data not shown), was transiently expressed in HEK293 T cells and subjected to GST pull-down analysis. The results showed that 17-AAG had little effect on binding of this fragment to GST-PCNA and GST-Ub ( Figure 5B ). This fragment displayed low binding to PCNA compared with the full-length Pol h protein, possibly because of the lack of the recently identified PIP-1 domain (Acharya et al., 2008) . Of note, the fragment showed much higher binding to Ub than did fulllength Pol h, suggesting that binding of the UBZ domain to Ub is regulated by intra-and/or intermolecular mechanisms.
To further confirm the physiological role of this regulatory mechanism, we examined effects of Hsp90 inhibition on endogenous Pol h binding to PCNA and Ub. To this end, cell extracts from vehicle-or 17-AAG-treated HEK293 T cells were incubated with GST-proteins. 17-AAG treatment significantly reduced Pol h amounts in GST-PCNA and GST-Ub pull-down fractions, despite its minimal effects on Pol h levels in input lysates ( Figures  5C and 5D ). Taken together, our results indicate that Hsp90 regulates the conformation of Pol h with respect to binding Ub-PCNA.
In an attempt to recapitulate the function of Hsp90 in vitro, FLAG-Pol h was synthesized in RRL, either in the presence or absence of 17-AAG, and was subjected to GST pull-down analysis. However, Pol h proteins translated in vitro displayed much lower binding to PCNA and Ub compared with Pol h in cell extracts, regardless of the presence of 17-AAG ( Figure S6 ). This suggests that Pol h failed to take a functional conformation in this system. Some Hsp90 clients, such as steroid receptors, require constitutive association with Hsp90 to keep their functional conformation (Pratt et al., 2006) , whereas other clients, such as protein kinases, transiently interact with the chaperone to be folded into functional forms and released (Arlander et al., 2006) . To examine which group Pol h belongs to, we first determined the subcellular localization of the Pol h/Hsp90 complex in 293 T/GFP-Pol h cells. Cell fractionation studies showed that the complex was detected in the soluble fraction, but not in chromatin, in nonirradiated and UV-irradiated cells ( Figure 6A ). We next asked whether or not Hsp90-free Pol h efficiently bound to GST-PCNA and GST-Ub. To this end, we immunodepleted Hsp90 from cell extracts, which reduced GFP-Pol h by $10%, but this had little effect on Pol h binding to GST-PCNA or GSTUb ( Figure 6B ). These data suggest that constitutive association with Hsp90 is not required for Pol h binding to PCNA or Ub. Thus, we postulate that Hsp90 transiently associates with Pol h in the soluble fraction and facilitates its folding into a mature form.
Effects of Hsp90 Inhibition on Pol h-Mediated TLS
To elucidate the role of Hsp90 in the regulation of Pol h-catalyzed TLS, we first studied the effects of 17-AAG on UV-induced cytotoxicity. Under 17-AAG treatment, HeLa and HEK293 T cells were $1.4-and $2-fold more sensitive to UV, respectively ( Figure 7A ). Although the exact reason for the different responses of the two cell lines is unknown, HeLa cells might depend to a lesser degree on Pol h in the context of UV sensitivity. We next monitored the amounts of UV-induced CPDs and (6-4)PPs in vehicle-and 17-AAG-treated cells. The results suggest that 17-AAG had little effect on the repair kinetics of these lesions ( Figure S7 ). To confirm that the 17-AAG-induced potentiation of UV-induced cytotoxicity is dependent on Pol h, we generated HEK293 T clones stably expressing Pol h shRNA (293 T/ sh-Pol h) and control clones stably expressing GFP shRNA (293 T/sh-GFP). In two 293 T/sh-Pol h clones, Pol h levels were suppressed compared with two 293 T/sh-GFP control clones ( Figure 7B ). Whereas 17-AAG enhanced UV-induced cytotoxicity in the control clones, this effect was much smaller in the 293 T/sh-Pol h clones ( Figure 7C and data not shown) . with or without 500 nM 17-AAG for 6 hr. The CSK buffer-insoluble fraction was solubilized after crosslinking with formaldehyde as described . Cell extracts were immunoprecipitated (IP) with control IgG (cIg) or the indicated antibodies followed by immunoblotting or directly immunoblotted as indicated. An arrowhead indicates a nonspecific signal.
These data indicate that the 17-AAG-induced UV sensitization is due to suppression of Pol h functions. We next studied the effects of Hsp90 inhibition on UV-induced mutagenesis. For this purpose, we used a supF shuttle vector, pSP189 (Parris and Seidman, 1992) . UV-irradiated pSP189 was transfected into and replicated in HEK293 T cells. In this assay system, siRNA knockdown of Pol h increased UV-induced mutagenesis (data not shown), as previously described (Choi and Pfeifer, 2005) . Of note, 17-AAG treatment significantly increased UV-induced mutation rates of pSP189 in these cells ( Figure 7D ). Similar results were obtained in WI-38VA13 cells (data not shown). These effects of 17-AAG were not due to different replication rates of pSP189, given that similar amounts of plasmid DNA were recovered in vehicle-treated and 17-AAGtreated cells (data not shown). Moreover, whereas 17-AAG increased UV-induced mutagenesis in two 293 T/sh-GFP control clones as seen in parental HEK293 T cells, these effects were abrogated in two 293 T/sh-Pol h clones ( Figure 7E ), indicating that the effects of 17-AAG on UV-induced mutagenesis depend on Pol h. The majority of supF mutants were G/C-to-A/T transitions at dipyrimidine sites in both vehicle-treated and 17-AAG-treated cells ( Figure S8 ). Earlier studies reported that transversions are the predominant UV-induced mutation types in XP-V cells (Wang et al., 1991; Wang et al., 1993) . By contrast, a recent study documented that transitions are predominant in normal and XP-V cells (Stary et al., 2003) , and similar results were obtained in a study using Pol h-depleted HEK293 T cells (Choi and Pfeifer, 2005 ). The precise reason for the contradictory results is unknown but may be related to the differences in the cells and assay methods used. Our results are consistent with the findings of these recent studies (Stary et al., 2003; Choi and Pfeifer, 2005) .
DISCUSSION
Because Y-Pols catalyze potentially mutagenic TLS, their functions should be tightly regulated. PCNA serves as a platform to which Y-Pols dock, and Rad6/Rad18-mediated monoubiquitination of the Lys164 residue is critical for recruitment of Y-Pols (Friedberg et al., 2005; Lehmann et al., 2007; Yang and Woodgate, 2007) . Although PCNA-and Ub-binding regions were identified in Y-Pols, the regulatory mechanisms for their targeting to Ub-PCNA are largely unknown. Emerging evidence suggests that Pol h is regulated by posttranslational covalent modification, such as monoubiquitination, phosphorylation, and sumoylation, in higher eukaryotes (Bienko et al., 2005; Chen et al., 2008; Kim and Michael, 2008) . In cooperation with these mechanisms, chaperone-mediated folding and the proteasome-mediated proteolysis may regulate the functions of the polymerase. Indeed, previous studies have shown that the GroE chaperone and the proteasome regulate bacterial and yeast Y-Pols, respectively (Donnelly and Walker, 1989; Layton and Foster, 2005; McIntyre et al., 2006 McIntyre et al., , 2007 Podlaska et al., 2003; Skoneczna et al., 2007) . In the present work, we identified Hsp90 as a critical regulator of Pol h in human cells. Hsp90 promotes Pol h accumulation at fork stalling sites through regulation of its stability/ solubility and its binding to Ub-PCNA. Our model is schematically illustrated in Figure S9 .
Several lines of evidence in the present work establish that Pol h is a client of Hsp90. First, Hsp90 specifically interacted with Pol h in vivo and in vitro. Another line of evidence is that 17-AAG suppressed UV-induced accumulation of Pol h at replication foci. In several cell types, including HeLa cells, 17-AAG reduced Pol h protein levels by accelerating proteasomal degradation. The reduction was more prominent in the soluble fraction, probably due to decreased solubility. Moreover, RNAi-mediated depletion of Hsp90 reduced Pol h protein levels and UV-induced focus formation. Thus, Pol h has the typical features of Hsp90 clients. Because Pol h is highly mobile between nucleoplasm and replication foci (Sabbioneda et al., 2008; Solovjeva et al., 2005) , the 17-AAG-induced reduction of Pol h in the soluble fraction is presumably a major contributor to its reduced localization in nuclear foci in some cell types.
Importantly, the mild reduction of Pol h in HEK293 T cells allowed us to find that Hsp90 regulates the binding of Pol h to Ub-PCNA. 17-AAG significantly reduced this binding in vivo. Furthermore, Pol h extracted from 17-AAG-treated cells exhibited low binding to PCNA and Ub in vitro. Thus, we propose the present model in which the Hsp90 chaperone cycle is required for the folding of Pol h into an active form to enable efficient Ub-PCNA binding ( Figure S9 ). We cannot completely exclude the possibility that Hsp90 inhibition suppresses Pol h binding to Ub-PCNA by indirect mechanisms. For instance, Hsp90 inhibition could increase an unknown factor(s) preventing the PIP-PCNA and/or UBZ-Ub interactions. However, this is unlikely because 17-AAG had no effect on in vitro PCNA and Ub binding or in vivo localization in nuclear foci (data not shown) of the C-terminal fragment (594-713).
The importance of conformational regulation of Pol h with respect to binding Ub-PCNA was further supported by our quantitative analysis of GST pull-down data. First, full-length Pol h exhibited much lower binding to Ub than did the C-terminal fragment (594-713), consistent with intramolecular masking of the UBZ domain. Second, in vitro translated Pol h showed much lower binding to PCNA and Ub than did the protein from cell lysates. The most likely explanation is that lack of Hsp90 cochaperones or other cofactors prevents folding of Pol h into the active form. An alternative, but not mutually exclusive, explanation is that posttranslational modification, such as phosphorylation, may be required to achieve the active conformation. It is a challenge for the future to identify these molecular mechanisms.
There are still controversies regarding the molecular mechanisms by which Pol h is targeted to replication stalling sites. For instance, it has been proposed that Pol h binds to other ubiquitinated proteins besides Ub-PCNA because Pol h moves in replication foci without PCNA monoubiquitination (Sabbioneda et al., 2008) . Although some researchers have questioned the role of the UBZ domain (Acharya et al., 2008) , there is an agreement among most researchers that the interactions of Pol h with PCNA and Ub are critical for its localization in replication foci. Thus, our findings should provide an important basis for studying protein interactions of Pol h. The Hsp90-depleted or mock-treated lysates were subjected to GST pulldown as indicated, and pull-down fractions were immunoblotted with antiPol h antibody.
Hsp90 constitutively associates with certain nuclear proteins, such as steroid receptors and telomerase (Forsythe et al., 2001; Holt et al., 1999; Pratt et al., 2006; Toogun et al., 2008) , regulating their functions at multiple levels. However, our observations suggest that this is not the case with Pol h. First, Hsp90/Pol h association was detectable in the soluble fraction, but not in the chromatin, before and after UV irradiation. Moreover, immunodepletion of Hsp90 had little effect on Pol h binding to PCNA and Ub. These data support the present model wherein Hsp90 transiently associates with the inactive form, promoting its folding into the active form and releasing it into the soluble fraction.
Hsp90 inhibition potentiates UV-induced cytotoxicity and mutagenesis. Interpretation of these functional data is complicated because a number of proteins interact with each other in the DNA damage response network, and Hsp90 regulates multiple client proteins in this network. In other words, our functional assays of Pol h may be affected by other Hsp90 client proteins. For instance, FANCA is degraded after 17-AAG treatment (Oda et al., 2007) , which could suppress UV-induced mutagenesis through the regulation of REV1 (Mirchandani et al., 2008) . Conversely, Hsp90 inhibition may stimulate supF mutagenesis through unknown pathways. To overcome such problems, we examined the effects of 17-AAG in Pol h-depleted cells. Our results showed that the effects of 17-AAG on UV-induced cytotoxicity and mutagenesis are abolished by Pol h depletion, confirming that the effects of 17-AAG are dependent on Pol h. Given that Hsp90 activity is elevated in tumor cells (Kamal et al., 2003; Whitesell and Lindquist, 2005) , the link between Hsp90 and Pol h provides important insights into aberrant genotoxic responses in tumor cells. Specifically, Hsp90-mediated facilitation of Pol h targeting for TLS may contribute to tumor progression through at least two mechanisms. First, an efficient replicative bypass of cytotoxic drug-induced DNA adducts will lead to a tumor cell survival advantage. Indeed, Pol h replicates across cisplatin-induced intrastrand crosslinks, contributing to cellular resistance to the drug (Albertella et al., 2005; Alt et al., 2007; Vaisman et al., 2000) . In addition, deficiency of Pol h causes cellular hypersensitivity to various drugs, such as gemcitabine (Chen et al., 2006) . Thus, Hsp90 inhibitor-induced sensitization to cytotoxic drugs may be partly explained by impaired function of Pol h. In this scenario, Hsp90 inhibition may be useful for preventing malignant progression and the emergence of drug resistance in tumors.
EXPERIMENTAL PROCEDURES Cells SV40-transformed human cell lines XP2SASV3 (skin fibroblasts), WI-38VA13 (embryo lung fibroblasts), and HEK293 T (embryo kidney cells), as well as other cell lines, including HeLa (human cervical cancer cells), MCF7 (human breast cancer cells), and COS7 (SV40-transformed African green monkey kidney cells) were maintained in Dulbecco's modified Eagle medium containing 10% fetal bovine serum. HeLa and HEK293 T cells stably expressing GFP or GFP-Pol h were obtained using pLPCX/GFP or pLPCX/GFP-Pol h. HEK293 T cells stably expressing shRNAs of GFP and Pol h were obtained using pLKO.1/sh-GFP and pLKO.1/sh-Pol h recombinant lentivirus vectors, respectively. For transient expression, subconfluent cells were transfected with FuGENE 6 (Roche). siRNAs were transfected using Lipofectamine 2000 (Invitrogen).
Cell Extracts
WCL for immunoblotting studies were prepared by lysing cells in Laemmli buffer. Cell lysates for immunoprecipitation were prepared as described (Oda et al., 2007) . For fractionation studies, cells were extracted in CSK buffer and centrifuged at 5000 3 g for 5 min at 4 C, as described , and the supernatant was collected as a soluble fraction. The pellet was suspended and incubated in buffer containing micrococcal nuclease (2 U/ml) as described (Yuasa et al., 2006) . The sample was then centrifuged at 15,000 3 g for 10 min at 4 C. The supernatant and pellet were used as chromatin and insoluble fractions, respectively.
Immunoprecipitation, Immunoblotting, and GST Pull-Down Immunoprecipitation and immunoblotting were performed by standard procedures. For immunoprecipitation and immunoblotting of Pol h, rabbit polyclonal (H-300) and mouse monoclonal (B7) antibodies were used, respectively. Protein signals were densitometrically quantified using National Institutes of Health Image software (ImageJ). GST pull-down experiments were performed using indicated amounts of GST or GST-fusion proteins for each assay, as described (Bienko et al., 2005 ). An amount of GFP-Pol h in a standard solution was determined by immunoblotting with anti-Pol h antibody by comparison with a standard curve using known amounts of immunopurified FLAG-Pol h.
Fluorescence Microscopy
Cells were fixed with methanol for 10 min at À30 C and stained with anti-PCNA antibody (sc-56, Santa Cruz Biotechnology). Microscopy was performed as described previously (Oda et al., 2007) . To score nuclear focipositive cells, at least 200 nuclei were examined at original magnification X 200, and nuclei containing more than ten bright foci were scored as positive.
Semiquantitative RT-PCR Total RNA was isolated using TRIzol reagent (Invitrogen). Reverse transcription reactions were performed from 1 mg total RNA using ReverTra Ace (TOYOBO), and then PCR proceeded in a mixture containing cDNA templates, ExTaq HS polymerase (TaKaRa), and appropriate primers. The numbers of PCR cycles were 32 and 26 for Pol h and glyceraldehyde 3-phosphate dehydrogenase (GAPDH), respectively; the relationship between the band intensity and the number of PCR cycles was linear.
Cell Survival Assay Cells were seeded in 35 mm tissue culture dishes at a density of 2 3 10 5 cells/ dish and allowed to grow overnight. Next, cells were UV irradiated as indicated and then incubated in culture medium containing indicated agents and 1 mM caffeine for 16 hr. Cells were replated in 96-well tissue culture plates at a density of 5 3 10 3 cells/well and then incubated with 1 mM caffeine for 72 hr. Cell survival was colorimetrically measured as described (Oda et al., 2007) .
SupF Mutation Assay
The pSP189 plasmid DNA (50 mg) dissolved in 1 ml of TE buffer (10 mM Tris [pH 7.5], 1 mM EDTA) was irradiated with 100 J/m 2 UV in a sterile plastic 60 mm tissue culture dish. The plasmid DNA was then precipitated with ice-cold ethanol, redissolved in TE buffer, and transfected into indicated cells using FuGENE6. After 48 hr, the plasmid DNA was isolated, and mutation frequency of supF was determined as described (Choi and Pfeifer, 2005) .
Statistical Analysis
Statistical analyses were performed using a two-tailed Student's t test. 
SUPPLEMENTAL INFORMATION
